MAZE (STOCKS)
Maze Therapeutics, Inc. Common Stock
$27.660000
+0.970000 (+3.63%)
Prev close: $26.690000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jason V. Coloma
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,362.51M
- Employees
- 125
- P/E (TTM)
- -9.64
- P/B (TTM)
- 3.71
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.65 | $-0.73 | +0.0779 | +10.70% |
|
Sep 2025 (Q3)
|
$-0.66 | $-0.72 | +0.0627 | +8.68% |
|
Jun 2025 (Q2)
|
$-0.77 | $-0.87 | +0.1031 | +11.81% |
|
Mar 2025 (Q1)
|
$-1.15 | $-0.77 | -0.3816 | -49.66% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $142.90M |
| Research and Development | $108.45M |
| Other Operating Expenses | $34.45M |
| Operating Income/Loss | -$142.90M |
| Income/Loss From Continuing Operations After Tax | -$131.12M |
| Income/Loss From Continuing Operations Before Tax | -$131.12M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$131.12M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$131.12M |
| Net Income/Loss Available To Common Stockholders, Basic | -$131.12M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.05 |
| Diluted Earnings Per Share | -$3.05 |
| Basic Average Shares | 42,976,024 |
| Diluted Average Shares | 42,976,024 |
| Assets | $397.13M |
| Current Assets | $349.72M |
| Noncurrent Assets | $47.41M |
| Fixed Assets | $5.04M |
| Other Non-current Assets | $42.37M |
| Liabilities | $42.16M |
| Current Liabilities | $22.56M |
| Accounts Payable | $1.79M |
| Wages | $10.85M |
| Other Current Liabilities | $9.91M |
| Noncurrent Liabilities | $19.61M |
| Equity | $354.97M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $354.97M |
| Temporary Equity | $0.00 |
| Temporary Equity Attributable To Parent | $0.00 |
| Liabilities And Equity | $397.13M |
| Net Cash Flow From Operating Activities | -$111.94M |
| Net Cash Flow From Operating Activities, Continuing | -$111.94M |
| Net Cash Flow From Investing Activities | -$170.96M |
| Net Cash Flow From Investing Activities, Continuing | -$170.96M |
| Net Cash Flow From Financing Activities | $275.34M |
| Net Cash Flow From Financing Activities, Continuing | $275.34M |
| Net Cash Flow | -$7.57M |
| Net Cash Flow, Continuing | -$7.57M |
| Comprehensive Income/Loss | -$131.01M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$131.01M |
| Other Comprehensive Income/Loss | $110.00K |